Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
INCB050465 (Parsaclisib), Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the INCB050465 (Parsaclisib) for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
Dysmenorrhea - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Dysmenorrhea Understanding ... Read More
-
PrimeC Emerging Drug Insight and Market Forecast – 2032
... of the primeC for Amyotrophic Lateral Sclerosis in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Dupilumab Emerging Drug Insight and Market Forecast – 2032
... Dupilumab for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
Behçet disease - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Limb Girdle Muscular Dystrophy - Pipeline Insight, 2022
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
SUNOSI (Solariamfetol), Drug Insight and Market Forecast – 2032
... picture of the SUNOSI (Solariamfetol) for Excessive Daytime Sleepiness (EDS) in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
VRAYLAR, Emerging Drug Insight and Market Forecast – 2032
... of the VRAYLAR for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
BIVV020 (SAR445088), Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the BIVV020 (SAR445088) for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
Rare NRG1 Fusion - Market Insight, Epidemiology and Market Forecast -2032
... epidemiology as well as the Rare NRG1 Fusion market trends in the United States, the EU-5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Rare NRG1 Fusion market report provides current treatment ... Read More
-
Epidemic keratoconjunctivitis (EKC)—Market Insights, Epidemiology, and Market Forecast–2032
... trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The EKC market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and ... Read More
-
Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... well as the pancreatic cancer market trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The pancreatic cancer market report provides current treatment practices, emerging drugs, and market ... Read More
-
Deep Vein Thrombosis - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Hereditary Angioedema - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Osteogenesis imperfecta (OI) - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
ANX005, Emerging Drug Insight and Market Forecast – 2032
... the ANX005 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Pegcetacoplan (APL-2), Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Pegcetacoplan (APL-2) for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
Dystrophic Epidermolysis Bullosa - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the market trends of Dystrophic Epidermolysis Bullosa (DEB) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Dystrophic Epidermolysis Bullosa (DEB) market report provides ... Read More
-
Gastrointestinal Stromal Tumor (GIST) - Market Insight, Epidemiology And Market Forecast - 2032
... as well as the GIST market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The GIST market report provides current treatment practices, emerging drugs, and market share ... Read More
-
Onychomycosis - Market Insight, Epidemiology And Market Forecast - 2032
... the market trends of onychomycosis in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan and China. The onychomycosis market report provides current treatment practices, emerging drugs, market share of the individual ... Read More
-
Essential tremor - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Neurofibromatosis Type 2 - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2022
... (Wet-AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
SLS-005 Emerging Drug Insight and Market Forecast – 2032
... the SLS-005 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
CIMZIA (Certolizumab pegol) Drug Insight and Market Forecast – 2032
... A detailed picture of the CIMZIA (Certolizumab pegol) for Crohn’s disease (CD) in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is ... Read More
Research Assistance
